The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Avience Biomedicals IPO
Avience Biomedicals
SMEListed

Avience Biomedicals IPO

Bidding 18-22 Jun 2026, price band ₹196–208, lot 600 shares.

+90%
listing gain
OverviewGMPSubscriptionAllotment

Grey Market Premium Trend

GMP last updated: 25 Jun 2026, 9:36 AM IST

₹145
Final GMP
90%
Actual Listing Gain
69.7%
GMP-Implied Gain
₹196 - ₹208
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
24 Jun₹145₹35369.71%
23 Jun₹145₹35369.71%
22 Jun₹95₹30345.67%
21 Jun₹72₹28034.62%
20 Jun₹70₹27833.65%
19 Jun₹85₹29340.87%
18 Jun₹85₹29340.87%
17 Jun₹85₹29340.87%
16 Jun₹75₹28336.06%
15 Jun₹63₹27130.29%
14 Jun₹70₹27833.65%
13 Jun₹0₹2080.00%
12 Jun₹0₹2080.00%

IPO timeline

  1. Issue open date
    18 Jun 2026
  2. Issue close date
    22 Jun 2026
  3. UPI mandate deadline
    22 Jun 2026
  4. Allotment finalization
    23 Jun 2026
  5. Refund initiation
    24 Jun 2026
  6. Share credit
    24 Jun 2026
  7. Listing date
    25 Jun 2026
  8. Mandate end date
    7 Jul 2026
  9. Lock-in end date for anchor investors (50%)
    22 Jul 2026
  10. Lock-in end date for anchor investors (remaining)
    20 Sep 2026

Avience Biomedicals IPO Allotment Status

Allotment date:23 Jun 2026
Registrar:Skyline Financial Services Private Ltd
  1. Open the registrar's allotment page from the link below.
  2. Select Avience Biomedicals from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on Skyline Financial Services(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:24 Jun 2026
Shares credited to demat:24 Jun 2026
Listing:25 Jun 2026
💸

IPO Subscription Status

CategoryTimesEst. Allotment Chances*
HNIs (Total)597.17🔥0.17%
bHNI670.18🔥0.15%
sHNI451.17🔥0.22%
QIBs196.77🔥-
Retail399.89🔥0.25%
Total384.57🔥-

*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.

Last updated: 22 June'26 04:44PM

Quick Stats

Issue Size:30cr
Lot Size:600 shares
Min Investment (2 lots):₹2,49,600
P/E Ratio:11.59

Additional Resources

ProspectusRead(Opens in a new tab)

About the Company

Avience Biomedicals Limited is an Indian healthcare products company engaged in the manufacturing and supply of diagnostic kits, medical devices and related healthcare products. The company began its operations with diagnostic solutions such as Viral Transport Media (VTM) and test kits for diseases including COVID-19, HIV, HBsAg, malaria and dengue. Over time, it expanded its portfolio to include in-vitro diagnostic (IVD) rapid test kits, serology products, biochemistry analysers and biochemistry reagents. The company serves the healthcare sector by providing products used in disease detection, diagnosis and laboratory testing. Its revenue is primarily generated through the sale of these diagnostic and medical device products. Avience Biomedicals operates in the medical devices and diagnostics segment and focuses on offering healthcare solutions across multiple testing and diagnostic categories.

Strengths

  • Manufactures a wide range of diagnostic kits, medical devices, analysers and reagents.
  • Serves pathology labs, hospitals, research centres and other healthcare institutions.
  • Holds ISO 9001, ISO 13485, GMP and ZED MSME Gold certifications.
  • Operates a manufacturing facility in Noida with advanced processing capabilities.
  • Has expanded from diagnostic kits to a broader portfolio of healthcare products.

Risks

  • Business performance may be affected by changes in government policies and regulations.
  • Operations depend on the continued services of key management personnel and employees.
  • The company relies on third-party transportation and logistics providers.
  • Market demand and industry fluctuations can impact revenue and profitability.
  • The company has ongoing legal proceedings involving commercial and cheque dishonour matters.

Avience Biomedicals IPO – Frequently Asked Questions

  • The price band for the Avience Biomedicals IPO is set at ₹196 to ₹208 per share.
  • The Avience Biomedicals IPO opens on June 18, 2026 and closes on June 22, 2026.
  • The tentative listing date for the Avience Biomedicals IPO is June 25, 2026.
  • The last recorded Grey Market Premium (GMP) for the Avience Biomedicals IPO before listing was ₹145 (69.71%). GMP is unofficial and is not a guarantee of the listing price.
  • The Avience Biomedicals IPO listed on June 25, 2026 with a listing gain of 90% over its issue price.
  • The Avience Biomedicals IPO allotment date is June 23, 2026. Once it is finalised, check your status with your PAN or application number on the website of the registrar, Skyline Financial Services Private Ltd. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Avience Biomedicals IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Avience Biomedicals, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Avience Biomedicals IPO is 600 shares. As an SME IPO, individual investors must apply for at least 2 lots (i.e., 1200 shares), which costs ₹2,49,600 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent SME listings

  • Antala IndustriesListed 11 Nov 2026
    -20%
  • Vedant Poly FabsListed 9 Nov 2026
    0%
  • Johnsoncab ElectricalsListed 6 Nov 2026
    +19.25%
  • HGS (India)Listed 6 Nov 2026
    +33.33%
  • Vectras EnproconListed 6 Nov 2026
    +0.95%
  • Maxwell Engineering SolutionsListed 6 Nov 2026
    +90%

All IPOs that opened in June 2026